These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30647035)

  • 41. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
    Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
    J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive Capabilities of Three Widely Used Pathology Classification Systems and a Simplified Classification (Beijing Classification) in Primary IgA Nephropathy.
    Duan SW; Mei Y; Liu J; Chen P; Li P; Chen YZ; Lin SP; Zhang XG; Liu JN; Sun XF; Xie YS; Cai GY; Liu SW; Wu J; Chen XM
    Kidney Blood Press Res; 2019; 44(5):928-941. PubMed ID: 31461707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].
    Xu J; Hu XF; Huang W; Shen PY; Zhang W; Ren H; Li X; Wang WM; Chen N; Pan XX
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):924-929. PubMed ID: 29202533
    [No Abstract]   [Full Text] [Related]  

  • 44. [The pathogenetic influence of tubulointerstitial lesions on the glomerular function in IGg nephropathy: a study of 90 cases].
    Zhang G; Ye R; Li Y
    Zhonghua Nei Ke Za Zhi; 1996 Jul; 35(7):471-3. PubMed ID: 9592320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review of cases of IgA nephropathy.
    World MJ
    J R Army Med Corps; 2013 Jun; 159(2):90-3. PubMed ID: 23720589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of asymmetric dimethylarginine with severity of kidney injury and decline in kidney function in IgA nephropathy.
    Fujimi-Hayashida A; Ueda S; Yamagishi S; Kaida Y; Ando R; Nakayama Y; Fukami K; Okuda S
    Am J Nephrol; 2011; 33(1):1-6. PubMed ID: 21109733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between lifestyle, gender and risk for developing end-stage renal failure in IgA nephropathy: a case-control study within 10 years.
    Huang PP; Shu DH; Su Z; Luo SN; Xu FF; Lin F
    Ren Fail; 2019 Nov; 41(1):914-920. PubMed ID: 31580172
    [No Abstract]   [Full Text] [Related]  

  • 48. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
    Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
    Yoon CY; Chang TI; Kang EW; Lim BJ; Kie JH; Kee YK; Kim H; Park S; Yun HR; Jung SY; Jhee JH; Kwon YE; Oh HJ; Park JT; Yoo TH; Kang SW; Jeong HJ; Han SH
    Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk stratification of patients with IgA nephropathy.
    Barbour SJ; Reich HN
    Am J Kidney Dis; 2012 Jun; 59(6):865-73. PubMed ID: 22497792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
    Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy.
    Chin HJ; Cho HJ; Lee TW; Na KY; Oh KH; Joo KW; Yoon HJ; Kim YS; Ahn C; Han JS; Kim S; Jeon ES; Jin DC; Kim YL; Park SH; Kim CD; Song YR; Kim SG; Kim YG; Lee JE; Oh YK; Lim CS; Lee SK; Chae DW; Cho WY; Kim HK; Jo SK;
    J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S22-9. PubMed ID: 19194557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential Blood Pressure Goals in IgA Nephropathy: Prevalence, Awareness, and Treatment Rates in Chronic Kidney Disease Among Patients with Hypertension in China (PATRIOTIC) Study.
    Zheng Y; Wang Y; Liu S; Wu J; Duan S; Zhu H; Wu D; Cai G; Chen X
    Kidney Blood Press Res; 2018; 43(6):1786-1795. PubMed ID: 30504700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesangial C4d Deposits in Early IgA Nephropathy.
    Segarra A; Romero K; Agraz I; Ramos N; Madrid A; Carnicer C; Jatem E; Vilalta R; Lara LE; Ostos E; Valtierra N; Jaramillo J; Arredondo KV; Ariceta G; Martinez C
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):258-264. PubMed ID: 29146701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
    Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Amemiya N; Ochi A; Tsuruta Y; Shimizu A; Itabashi M; Takei T; Uchida K; Nitta K
    Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Neglected Significance of Glomerular Density as a 5-year Progression Indicator for IgA Nephropathy
    Chen ZJ; Li H; Cai JF; Zhang X; Li C; Zou PM; Li MX; Chen LM; Li XM; Li XW; Wen YB
    Chin Med Sci J; 2017 Sep; 32(3):145-151. PubMed ID: 28956741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anaemia and type 2 diabetes: implications from a retrospectively studied primary care case series.
    Chen CX; Li YC; Chan SL; Chan KH
    Hong Kong Med J; 2013 Jun; 19(3):214-21. PubMed ID: 23568938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G; Liu D; Margetts P; Liu L; Zhao Z; Liu Z; Tang L; Fang Y; Li H; Guo Y; Chen F; Liu F
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.